Atara Biotherapeutics (NASDAQ: ATRA) director reports 38,320-share common stock holding
Rhea-AI Filing Summary
Atara Biotherapeutics, Inc. director Brian N. Cherry filed an initial ownership report showing his holdings in the company’s common stock. The filing lists direct ownership of 38,320 shares of Common Stock after the reported holdings, with no specific buy or sell transaction disclosed.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Cherry Brian N
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 38,320 shares (Direct)
Footnotes (1)
Key Figures
Common Stock holdings: 38,320 shares
1 metrics
Common Stock holdings
38,320 shares
Total shares directly owned after reported holdings on Form 3
Key Terms
Common Stock, Form 3, reporting person
3 terms
Common Stock financial
"security_title: "Common Stock" is listed for the reported holding entry."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 3 regulatory
"Insider filing data is identified as a Form 3 initial beneficial ownership statement."
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
reporting person regulatory
"The filing lists Brian N. Cherry as a reporting person and director of the issuer."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Brian N. Cherry’s Form 3 filing for ATRA show?
The Form 3 filing shows that Brian N. Cherry, a director of Atara Biotherapeutics, directly holds 38,320 shares of Common Stock. It is an initial ownership report and does not reflect a new purchase or sale transaction.
Is Brian N. Cherry a ten percent owner of Atara Biotherapeutics (ATRA)?
No, the Form 3 indicates Brian N. Cherry is a director but not a ten percent owner. The filing flags him as a director only, with no indication that his 38,320 directly held shares reach ten percent ownership.
Does the ATRA Form 3 for Brian N. Cherry show any recent stock transactions?
The Form 3 does not show a specific buy or sell transaction. It classifies the entry as a holding, listing 38,320 shares of Common Stock directly owned after the reported holdings, rather than detailing a new trade.